Morgan Stanley’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50 Sell
10
-350
-97% -$1.75K ﹤0.01% 7782
2025
Q1
$2.88K Buy
360
+350
+3,500% +$2.8K ﹤0.01% 7101
2024
Q4
$74 Hold
10
﹤0.01% 7513
2024
Q3
$96 Hold
10
﹤0.01% 7448
2024
Q2
$124 Sell
10
-29
-74% -$360 ﹤0.01% 7328
2024
Q1
$848 Sell
39
-49
-56% -$1.07K ﹤0.01% 7188
2023
Q4
$800 Buy
88
+44
+100% +$400 ﹤0.01% 7233
2023
Q3
$1.27K Sell
44
-1
-2% -$29 ﹤0.01% 7205
2023
Q2
$3.85K Sell
45
-6
-12% -$513 ﹤0.01% 7040
2023
Q1
$21.6K Sell
51
-1
-2% -$423 ﹤0.01% 6598
2022
Q4
$62.6K Buy
52
+4
+8% +$4.82K ﹤0.01% 6192
2022
Q3
$38K Buy
48
+34
+243% +$26.9K ﹤0.01% 6526
2022
Q2
$20K Sell
14
-12
-46% -$17.1K ﹤0.01% 6980
2022
Q1
$54K Sell
26
-28
-52% -$58.2K ﹤0.01% 6666
2021
Q4
$262K Buy
54
+28
+108% +$136K ﹤0.01% 5915
2021
Q3
$160K Sell
26
-42
-62% -$258K ﹤0.01% 6109
2021
Q2
$643K Buy
+68
New +$643K ﹤0.01% 5366
2021
Q1
Sell
-18
Closed -$138K 7205
2020
Q4
$138K Buy
18
+17
+1,700% +$130K ﹤0.01% 5774
2020
Q3
$7K Sell
1
-2
-67% -$14K ﹤0.01% 6360
2020
Q2
$23K Buy
3
+2
+200% +$15.3K ﹤0.01% 5971
2020
Q1
$6K Sell
1
-10
-91% -$60K ﹤0.01% 6145
2019
Q4
$176K Buy
11
+8
+267% +$128K ﹤0.01% 5461
2019
Q3
$32K Buy
+3
New +$32K ﹤0.01% 5870
2019
Q2
Sell
-1
Closed -$18K 6638
2019
Q1
$18K Buy
+1
New +$18K ﹤0.01% 6033
2018
Q3
Sell
-1
Closed -$17K 6707
2018
Q2
$17K Sell
1
-3
-75% -$51K ﹤0.01% 6182
2018
Q1
$49K Buy
4
+1
+33% +$12.3K ﹤0.01% 5882
2017
Q4
$27K Buy
+3
New +$27K ﹤0.01% 5996
2016
Q2
Hold
0
6505
2016
Q1
Hold
0
6565
2015
Q4
Hold
0
6658